Skip to content
  • Home
  • How We Work
    • The Impact of Autophagy in Health and Disease
    • Biophagy’s Business Model
    • Biophagy’s Proprietary Drug Development
    • Cell Watchᵀᴹ
  • Business Development
  • Background & News
  • Team
  • Contact
Previous Next

Biophagy, working with Sandia National Laboratories, is awarded a grant from New Mexico Small Business Assistance (NMSBA) to develop spectroscopic assays for measuring autophagy and evaluating autophagy stimulant combinations.

By jordan|2022-03-22T20:43:30+00:00February 1, 2022|2014-announcements|0 Comments

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail

About the Author: jordan

Related Posts

  • Biophagy enters into a license agreement with the University of New Mexico (STC-UNM) to option multiple UNM curcumin and resveratrol analogs for pharmaceutical development.

    Biophagy enters into a license agreement with the University of New Mexico (STC-UNM) to option multiple UNM curcumin and resveratrol analogs for pharmaceutical development.

Leave A Comment Cancel reply

Copyright 2022 | All Rights Reserved | Website Design and Development by Ingenuity Software Labs
FacebookTwitterInstagramPinterest
Page load link
Go to Top